sps4251

Small moleculeexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Mar 1, 2013 (NCT01743118)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • sps4251

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01743118Phase 1Mar 1, 2013Bioskin GmbH, Circassia Limited
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Bioskin GmbHFor profit1012013
Circassia LimitedFor profit1112013
2 organizations
Page 1 / 1